Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Orgenesis Inc
ORGSCurrent price
0.54 USD
-0.023 USD (-4.09%)
Last closed
0.55 USD
Company
www.orgenesis.com
ISIN
US68619K2042
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
28 526 256 USD
Yield for 12 month
-15.33 %
1Y
3Y
5Y
10Y
15Y
ORGS
Orgenesis Inc., a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. The company also provides development services, including regulatory services, pre-clinical studies, intellectual property services, and GMP process translation, as well as support services; hospital services; cell process development services; and distributed cell processing services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland. Address: 20271 Goldenrod Lane, Germantown, MD, United States, 20876
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6 USDP/E ratio
–Dividend Yield
–Current Year
+530 000 USD
Last Year
+36 025 000 USD
Current Quarter
+246 000 USD
Last Quarter
+141 000 USD
Current Year
-5 725 000 USD
Last Year
+15 585 000 USD
Current Quarter
-749 000 USD
Last Quarter
-617 000 USD
Key Figures ORGS
1 year
3 years
5 years
10 years
EBITDA
-19 063 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-30.08 %
PEG Ratio
–
Return On Equity TTM
-727.25 %
Wall Street Target Price
6 USD
Revenue TTM
662 000 USD
Book Value
-0.33 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
117.7 %
Dividend Yield
–
Gross Profit TTM
36 025 000 USD
Earnings per share
-0.8 USD
Diluted Eps TTM
-0.8 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ORGS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ORGS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:12
Payout Ratio
–
Last Split Date
16.11.2017
Dividend Date
16.11.2017
Stock Valuation ORGS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
62.6439
Price Sales TTM
43.091
Enterprise Value EBITDA
-4.9808
Price Book MRQ
1.2558
Financials ORGS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ORGS
For 52 weeks
0.25 USD
1.08 USD
50 Day MA
0.71 USD
Shares Short Prior Month
445 474
200 Day MA
0.57 USD
Short Ratio
1.27
Shares Short
405 114
Short Percent
0.98 %
BeatStart